SRTS
Sensus Healthcare, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.19
−2.15%Year over year
Reported trailing growth
- Revenue
- -53.4%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +43.9%
- EBITDA
- +60.5%
- EPS
- +73.6%
Three-year CAGR
- Revenue
- -14.9%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +130.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026